Nasdaq · CIK 0001729427
CNSP CNS Pharmaceuticals, Inc.
Insider trading from SEC Form 4. Last filing Mar 4, 2026.
Last 90 days
Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
10
with a Form 4 at this company
Signals
Open-market buys and sells at CNS Pharmaceuticals, Inc., scored.
No scored open-market trades yet. Grants, exercises and other rows are below.
Transactions
The last 10 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 2, 2026 | Steve O'Loughlin Chief Financial Officer | AGrant or award Restricted Stock Unitsderivative | +9,500 | - | - | 9,500 | Mar 4, 2026 |
| Mar 2, 2026 | Eric Faulkner Chief Technology Officer | AGrant or award Restricted Stock Unitsderivative | +9,500 | - | - | 9,500 | Mar 4, 2026 |
| Jan 1, 2026 | Rami Levin CEO and President | AGrant or award Restricted Stock Unitsderivative | +19,000 | - | - | 19,000 | Jan 2, 2026 |
| Nov 17, 2025 | Jerzy Gumulka director | AGrant or award Option to purchase common stockderivative | +1,517 | $0.00 | $0 | 1,517 | Nov 19, 2025 |
| Nov 17, 2025 | Christopher Downs Chief Financial Officer | AGrant or award Option to purchase common stockderivative | +4,881 | $0.00 | $0 | 4,881 | Nov 19, 2025 |
| Nov 17, 2025 | Faith L. Charles director | AGrant or award Option to purchase common stockderivative | +1,517 | $0.00 | $0 | 1,517 | Nov 19, 2025 |
| Nov 17, 2025 | John M Climaco Chief Executive Officer | AGrant or award Option to purchase common stockderivative | +9,761 | $0.00 | $0 | 9,761 | Nov 19, 2025 |
| Nov 17, 2025 | Amy Mahery director | AGrant or award Option to purchase common stockderivative | +1,517 | $0.00 | $0 | 1,517 | Nov 19, 2025 |
| Nov 17, 2025 | Bettina M. Cockroft director | AGrant or award Option to purchase common stockderivative | +1,517 | $0.00 | $0 | 1,517 | Nov 19, 2025 |
| Nov 17, 2025 | Jeffry R. Keyes director | AGrant or award Option to purchase common stockderivative | +1,517 | $0.00 | $0 | 1,517 | Nov 19, 2025 |
Insiders
Everyone who has filed a Form 4 here.
- Faith L. Charlesdirector
- John M ClimacoChief Executive Officer
- Bettina M. Cockroftdirector
- Christopher DownsChief Financial Officer
- Eric FaulknerChief Technology Officer
- Jerzy Gumulkadirector
- Jeffry R. Keyescfo, officer, director
- Rami LevinCEO and President
- Amy Maherydirector
- Steve O'LoughlinChief Financial Officer
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.